EARLY HCV VIRAL KINETICS UNDER DAAs MAY OPTIMIZE DURATION OF THERAPY IN PATIENTS WITH COMPENSATED CIRRHOSIS

BACKGROUND AND AIMS: Detailed hepatitis C virus (HCV) kinetics modeling is scarce in patients with advanced liver disease receiving direct-acting antivirals (DAAs). Due to budget restrictions, patients and health systems would benefit from the shortest possible treatment course. We investigated whet...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Liver Int
Prif Awduron: Gambato, Martina, Canini, Laetitia, Lens, Sabela, Graw, Frederik, Perpiñan, Elena, Londoño, Maria-Carlota, Uprichard, Susan L., Mariño, Zoe, Reverter, Enric, Bartres, Concepcio, González, Patricia, Pla, Anna, Costa, Josep, Burra, Patrizia, Cotler, Scott J., Forns, Xavier, Dahari, Harel
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2018
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6483833/
https://ncbi.nlm.nih.gov/pubmed/30499631
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14014
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg